Meet the Partners

Cambridge Network

A not-for-profit membership organisation that brings people together from business and academia to exchange ideas, foster collaboration and build partnerships for shared success. It will play a central role in facilitating collaboration, leveraging its extensive connections with multidisciplinary partners from academia, research and industry.

Cambridge Neuroscience

Cambridge Neuroscience gives Fellows access to a virtual Interdisciplinary Research Centre at the University of Cambridge which serves to connect ~900 neuroscientists across all 6 schools of the University and has membership spanning more than 30 Departments and affiliated institutions.

Cambridge University Health Partners (CUHP)

Cambridge University Health Partners (CUHP) have developed and are responsible for delivering a unified, cross-cluster life sciences strategy for the Cambridge region. Informed by the local healthcare and life sciences community, this strategy is designed to attract global talent and investment, with the goal of delivering world-leading healthcare innovations and driving economic growth.

CUHP leads the Cambridge NeuroWorks consortium and serves as the grant-holding Activation Partner for ARIA. CUHP will support Fellows and other participants in the programme by helping them navigate the diverse academic, industry, and NHS organisations within Cambridge, thereby accelerating the translation of their research into real-world impact.

Cambridgeshire and Peterborough NHS Foundation Trust

With 4,500 staff and serving a population of just under a million people, CPFT will allow Cambridge NeuroWorks to access a leading mental health services research trust, which is also spearheading the programme for a new Children’s hospital due to be built in Cambridge, that uniquely combines mental and physical treatment on the same wards.

Maxwell Centre

The Maxwell Centre is the centrepiece of academia-industry engagement at the University of Cambridge, actively interfacing leading research in Physical Sciences and Technology with industry and catalysing impactful innovation. The Maxwell Centre has been driving interdisciplinary interactions and collaborations with companies in Cambridge since 2016, aligning and connecting expertise to co-develop solutions within strategic challenge areas. It will actively facilitate Fellows' engagement with leading research in physical sciences and engineering during their 'Blue Sky' experimental exploration.

The Milner Therapeutics Institute

The Milner Therapeutics Institute (MTI) encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies. The MTI is breaking new ground in academic/industry interactions and demonstrates a world-leading model of start-up companies, academics and pharma working side by side at the bench. The Institute houses its own research teams, the Frame Shift Bio-incubator, and the Functional Genomics Screening Laboratory. MTI will give the programme access to a globally leading and unique model where visiting researchers can work with experts in health-tech/ neurosciences to ideate unboxed ideas. The MTI also leads on Connect: Health Tech, the virtual platform supporting pan-UK Cambridge NeuroWorks.

University of Cambridge

As well as convening its institutions like the Milner and Maxwell, and Cambridge Neuroscience as partners to this programme, the University will bring scientific leadership to this programme through Cambridge Neuroscience, the department of Engineering and the department of Psychiatry.

University of Cambridge Department of Engineering

University of Cambridge Department of Engineering is a global leader in innovation, it will provide Fellows with access to cutting-edge research, state-of-the-art facilities, and expertise in fields like AI, bioengineering, and sustainable systems.

University of Cambridge Department of Psychiatry

University of Cambridge Department of Psychiatry - is an internationally leading centre for research and teaching in psychiatry, with a particular focus on the determinants of mental health conditions, their treatments and the promotion of mental health through innovative translational research. It will offer access to expertise in understanding and treating mental health conditions through collaborative research groups and strong links with clinical and industry partners. Fellows will benefit from a rich network to advance innovations in neuropsychiatric care.

Vellos

Vellos co-founded by Prof Sir Tony Kouzarides – who also co-founded Abcam and the Milner Therapeutics Institute, is dedicated to advancing life science innovation through company creation and promotes impact at research institutions by empowering entrepreneurship and driving innovation through the creation of world-class ventures.